Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
Detection of cytosolic DNA by the enzyme cGAS triggers the production of cGAMP, a second messenger that binds and activates the adaptor protein STING, which leads to interferon (IFN) production. Here, we found that in vivo natural killer (NK) cell killing of tumor cells, but not of normal cells, dep...
Saved in:
Published in: | Immunity (Cambridge, Mass.) Vol. 49; no. 4; pp. 754 - 763.e4 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Elsevier Inc
16-10-2018
Elsevier Limited |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Detection of cytosolic DNA by the enzyme cGAS triggers the production of cGAMP, a second messenger that binds and activates the adaptor protein STING, which leads to interferon (IFN) production. Here, we found that in vivo natural killer (NK) cell killing of tumor cells, but not of normal cells, depends on STING expression in non-tumor cells. Experiments using transplantable tumor models in STING- and cGAS-deficient mice revealed that cGAS expression by tumor cells was critical for tumor rejection by NK cells. In contrast, cGAS expression by host cells was dispensable, suggesting that tumor-derived cGAMP is transferred to non-tumor cells, where it activates STING. cGAMP administration triggered STING activation and IFN-β production in myeloid cells and B cells but not NK cells. Our results reveal that the anti-tumor response of NK cells critically depends on the cytosolic DNA sensing pathway, similar to its role in defense against pathogens, and identify tumor-derived cGAMP as a major determinant of tumor immunogenicity with implications for cancer immunotherapy.
[Display omitted]
•Sting−/− mice, but not Cgas−/− mice, fail to mount optimal NK cell anti-tumor responses•Cgas−/− tumor cells are defective in inducing anti-tumor responses by NK cells•cGAS is constitutively active in tumor cells but not in untransformed cells•cGAMP is transferred from tumor cells to other cells in the TME to activate STING
Marcus et al. find that cGAMP produced by tumor cells triggers the activation of the STING pathway in immune cells within the tumor microenvironment. This leads to interferon production by these cells, which in turn activates NK cell anti-tumor immunity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 A.M., A.M.J, M.L.V, and L.W conducted the experiments and A.M., R.E.V and D.H.R designed the experiments and wrote the paper. Author contributions |
ISSN: | 1074-7613 1097-4180 |
DOI: | 10.1016/j.immuni.2018.09.016 |